Fact CheckerSign in

NCT07067229Recruiting

Non-invasive Brain Stimulation and Exercise Intervention for Patients With Motor Neuron Disease

Source: ClinicalTrials.gov · Last updated 25 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Motor neuron disease (MND) is a progressive neurological disorder involving degeneration of motor neurons, leading to muscle weakness, speech and swallowing difficulties, and respiratory failure. This study aims to develop a novel treatment approach combining personalized repetitive transcranial magnetic stimulation (rTMS) with mixed reality (MR) exercise-based games (exergames) to slow disease progression and improve quality of life. In this randomised controlled trial study will compare three groups: (1) rTMS with MR exercise (personalized intervention), (2) rTMS with MR exercise (standard intervention), and (3) sham rTMS with MR exercise. Outcomes will be assessed at baseline, 3 months, and 6 months post intervention. The long-term goal is to implement this approach in clinical settings to enhance care for people with MND.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
100 (estimated)
First submitted
5 Jul 2025
Start date
1 Aug 2025
Primary completion date
30 Aug 2027
Lead sponsor
Chulalongkorn University
NCT number
NCT07067229

What you commit to

  • Study type: Interventional
  • Planned participants: 100
  • From 1 Aug 2025 to the primary completion date, 30 Aug 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of other neurological disorders, such as stroke
  • Severe dementia

Other

  • Use of ventilatory support

Who the study is looking for

  • Participants aged between 18 and 80 years
  • Diagnosed with any type of motor neuron disease (MND)
  • Have mild to moderate severity, as assessed by the Sinaki-Mulder scale, with a severity level between 1 and 3

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
King Chulalongkorn Memorial hospital, The Thai Red Cross Society
Coordinator of this site? Confirm its status
BangkokThailandRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.